The recent investigation highlights the significance of targeted drug delivery of methotrexate utilizing hyaluronic acid-based albumin nanoparticles to deliver the loaded therapeutics in lymph nodes to suppress the immune cells of the acquired immune system in psoriasis through microneedle patch delivery (illustrated in Figure 7) [171]. This evidence concerns the gene ALB and psoriasis.